NTRB Nutriband Inc. - Common Stock

NASDAQ · Pharmaceuticals
$3.45
Price · Aug 18, 2026

NTRB Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$3.45
Market Cap
P/E (TTM)
EPS (TTM)
Revenue (TTM)
Div Yield
ROE
Debt/Equity
52W Range
$3 – $9

NTRB Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS
Free Cash Flow
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
NTRB
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
NTRB
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
NTRB
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
NTRB
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
NTRB
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
NTRB
Peer Median

NTRB Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 7 analysts
  • Strong Buy 2 28.6%
  • Buy 4 57.1%
  • Hold 1 14.3%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

1 analysts · 2026-08-13
Median target $15.00 +334.8%
Mean target $15.00 +334.8%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.67%
Next Report
Sep 07, 2026
Period EPS Actual EPS Est Surprise
March 31, 2026 $-0.08 $-1.93 1.8%
Dec. 31, 2025 $-0.32 $-2.17 1.9%
Sept. 30, 2025 $-0.18 $-0.17 -0.01%
June 30, 2025 $-0.12 $-0.16 0.04%
March 31, 2025 $-0.51 $-0.12 -0.39%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
NTRB
CNTX $135M -3.9 112.7% -50.5%
GRCE -9.9 -12.3%
HYPD $31M -0.4 1318.8% -5570.6% -115.6% 62.7%
FLNA -112.1%
GRCE -9.9 -12.3%
VERU $56M -5.4 3.6% -115.4%
MIRA $63M -1.1 -40.3% -10557.5% -190.5%
LLY 46.8 44.7% 31.7% 101.2%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 19 filers · $1.9M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
5 (+5 vs prior Q) 0 (-7 vs prior Q) 2 (0 vs prior Q) 3 (0 vs prior Q) +182K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD GROUP INC $794,169 174,927 42.92% Shares
VANGUARD CAPITAL MANAGEMENT LLC $558,017 174,927 30.16% Shares
GEODE CAPITAL MANAGEMENT, LLC $164,447 51,538 8.89% Shares
VANGUARD FIDUCIARY TRUST CO $80,104 25,111 4.33% Shares
STATE STREET CORP $79,642 24,966 4.30% Shares
CITADEL ADVISORS LLC $60,597 18,996 3.28% Shares
NORTHERN TRUST CORP $36,908 11,570 1.99% Shares
Haven Private, LLC $36,258 11,366 1.96% Shares
OSAIC HOLDINGS, INC. $9,889 3,100 0.53% Shares
Vanguard Global Advisers, LLC $8,613 2,700 0.47% Shares
WELLS FARGO & COMPANY/MN $8,294 2,600 0.45% Shares
Tower Research Capital LLC (TRC) $6,721 2,107 0.36% Shares
BlackRock, Inc. $2,131 668 0.12% Shares
Christopher J. Hasenberg, Inc $1,574 200 0.09% Shares
JONES FINANCIAL COMPANIES LLLP $1,426 466 0.08% Shares
CLEAR STREET LLC $787 100 0.04% Shares
UBS Group AG $638 200 0.03% Shares
BARCLAYS PLC $61 19 0.00% Shares
HARBOUR INVESTMENTS, INC. $10 3 0.00% Shares

Company insiders 4 insiders · 3 officers · 3 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Gareth Sheridan CEO March 20, 2024 A 1,510,000 0 0 $0
Gerald Goodman Chief Financial Officer June 6, 2024 M 0 0 $0
Serguei Melnik President and Secretary March 20, 2024 A 827,999 0 0 $0
Michael Davidov Director July 31, 2018 A 5,000 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 3 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Gareth Sheridan March 13, 2025 17.73% Initial filing Passive investment SEC
Serguei Melnik March 13, 2025 9.39% Initial filing Passive investment SEC
Undisclosed reporting person Jan. 23, 2024 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 3 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IWC · iShares Trust 0.00% 11,873 SH Aug. 8, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.00% 52,341 SH Aug. 8, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 122,586 SH Aug. 8, 2026 Daily